Huntington disease (HD) is a fatal neurodegenerative disease with no effective treatment. In the R6/1 mouse model of HD, environmental enrichment delays the neurologic phenotype onset and prevents cerebral volume loss by unknown molecular mechanisms. We examined the effects of environmental enrichment on well-characterized neuropathological parameters in a mouse model of HD. We found a trend toward preservation of downregulated neurotransmitter receptors in striatum of environmentally enriched mice and assessed possible enrichment-related modifications in gene expression using microarrays. We observed similar gene expression changes in R6/1 and R6/2 transgenic mice but found no specific changes in enrichmentrelated microarray expression profiles in either transgenic or wild-type mice. Furthermore, specific corrections in transprotein-induced transcriptional dysregulation in R6/1 mice were not detected by microarray profiling. However, gene-specific analyses suggested that long-term environmental enrichment may beneficially modulate gene expression dysregulation. Finally, environmental enrichment significantly decreased neuronal intranuclear inclusion load, despite unaffected transgene expression levels. Thus, the therapeutic effects of environmental enrichment likely contribute to decreasing aggregated polyglutamine protein levels without exerting strong effects on gene expression.
INTRODUCTION
Few effective treatments currently exist for many devastating neurodegenerative disorders, but epidemiologic evidence and studies in animal models of disease suggest that physical and cognitive stimulation can delay neurodegenerative manifestations, even in autosomal dominant genetic disorders such as Huntington disease (HD) (1, 2) . Understanding the mechanisms of environmental modulation of these diseases will help the development of therapies.
Huntington disease is a neurodegenerative disorder typically manifesting in midlife, with progressive cognitive, motor, and behavioral symptoms and signs (3). Huntington disease is caused by an expansion of a CAG repeat in exon 1 of the HTT gene that is translated into a polyglutamine repeat in the huntingtin (Htt) protein (4) . The R6 mouse models ubiquitously express exon 1 of the human HD gene with expanded CAG repeats and develop neuropathological, cognitive, and motor manifestations (5Y9). R6/1 mice express a transgene containing 115 CAG repeats at a lower level than the transgene in the well-characterized R6/2 line, which expresses more than 150 CAG repeats. Both lines develop neurologic phenotypes that are distinguishable only by age of onset and length of progression; based on home cage behavior, the onset is at 4 to 5 months in line R6/1 and at 2 months in R6/2.
Mutant Htt acts abnormally in neurons; the N-terminus of the protein is cleaved, ubiquitinated, and transported to the nucleus. Visible Htt-containing aggregates form in neuronal nuclei and processes before clinical onset; neuronal intranuclear inclusion (NII) sizes increase during the disease course (10) . Transcriptional dysregulation is a central molecular pathogenic mechanism in HD, and microarray analyses confirm selective downregulation of genes that are important to neuronal function, including specific neurotransmitter receptors (11Y14).
Environmental enrichment (EE) of rodents improves their performance on behavioral tests, induces morphologic changes in neurons, and upregulates gene expression even in aging brains (2, 15) . In the R6/1 mouse model of HD, EE delays the phenotype onset and prevents cerebral volume loss (16) ; behavioral benefits of environmental stimulation have been confirmed in the R6/2 line (17, 18) . Concomitant with amelioration of motor signs, home cage EE rescues specific protein deficits in R6/1 mice, suggesting that enrichment could rescue some of the gene expression deficits in HD (19, 20) . However, the molecular mechanisms of beneficial modulation by EE remain unknown. Here, we explore the potential effects of EE on gene expression, neurotransmitter receptor binding, and neuronal NII formation in R6/1 mice.
MATERIALS AND METHODS

Mice
Male R6/1 mice (5) were mated with female CBA past F10 to ensure an almost pure CBA background strain with 112Y120 CAG repeats (B6CBAF1/OlaHsd; Harlan Olac, Bicester, UK). Groups of 3 to 7 R6/1 transgenic (TG) and wild-type (WT) littermate control mice were housed in large rodent cages (44 Â 28 Â 12.5 cm 3 ) with food and water ad libitum. Home cage EE, consisting of novel objects that were replaced every 2 days (16, 20, 21) , was started for half the mice (randomly allocated to this group) after weaning at the age of 4 weeks. The remaining mice continued to receive standard housing. Mice of both sexes were used; they were randomly allocated to environmentally enriched/nonenriched (EE/NE) groups at weaning, so that that there were equivalent numbers of each sex in the different groups.
Phenotype onset in NE HD TG mice occurs around the age of 12 weeks, and all mice exhibited motor deficits by 24 weeks of age. In contrast, only 40% of EE TG mice displayed measurable motor deficits by 24 weeks of age. Therefore, we selected these ages to survey because they correspond to a measurable disease phenotype.
Mice were killed in accordance with Home Office guidelines and institutional requirements. Brains were taken from mice aged 12 and 24 weeks and frozen in chilled isopentane for neurotransmitter receptor binding, messenger RNA (mRNA) in situ hybridization, and immunohistochemical (IHC) analyses of NII. Dissected brain regions from 24-week-old mice were flash-frozen in liquid N 2 for DNA microarray analysis. Fixed brains from 48-week-old mice were used for ultrastructural analysis of inclusions.
Neurotransmitter Receptor Binding Autoradiography
Groups of 12-week-old mice (n = 32) were divided into 4 groups, namely, WT NE (n = 7), WT EE (n = 9), HD NE (n = 8), and HD EE (n = 8). Groups of 24-week-old mice (n = 24) were divided into 4 groups, namely, WT NE (n = 6), WT EE (n = 6), HD NE (n = 6), and HD EE (n = 6) were used. Quantitative autoradiographic receptor binding was performed on 12-Km parasagittal sections to assess receptor density in the HD mice, as previously described (22 
Microarray Expression Profiling
Dissected striata from 2 R6/1 or WT mice were pooled to yield 1 biologic replicate, with 3 replicates for each condition: WT NE, WT EE, R6/1 NE, and R6/1 EE. Total RNA (10 Kg) from each replicate was processed using the Affymetrix one-cycle T7 amplification protocol and hybridized to mouse genome U74Av2 arrays (Affymetrix, Santa Clara, CA). Gene expression measures for all probe sets were obtained using robust multiarray analysis using the affy software package (23) . Significant p values were corrected for multiple testing using a false discovery rate (FDR) approach as described (14) .
Striatal Transcriptional Regulation in R6/1 and R6/2
We first performed an analysis of differential gene expression in R6/1 and R6/2 mice separately as described (14) . Microarrays (3 control and 3 R6/1 replicates, hybridized on Affymetrix GeneChips MG-U74Av2) were used to identify genes differentially expressed in R6/1 versus WT mice. For R6/2 mice, samples were pooled from 2 separate experiments (n = 6 and 8, hybridized on Affymetrix GeneChips Mouse 430A 2.0). All 14 microarrays were analyzed together to test for differential gene expression in R6/2 versus WT samples (14) . To compare transcriptional changes detected in R6/1 and R6/2 mice, we mapped probe sets across the 2 different microarray formats using the R package BannotationTools[ from Bioconductor (www.bioconductor.org) as described (14, 24) . We selected the top 200 differentially expressed genes in R6/1 samples and plotted corresponding gene expression changes in R6/2 mice, as measured by log 2 -fold change and t-statistic. Concordant gene regulations were defined as gene expression changes of identical directions in both models (i.e. upregulated or downregulated in both). Finally, the association of the top 200 transcriptional changes in R6/1 and their corresponding regulation in R6/2 was tested using a nonparametric association measure (Kendall T).
Effects of EE on mRNA Expression Profiles
For the assessment of EE's effect in R6/1 mice, we used robust multiarray analysis to normalize all 12 microarrays (with R6/1 and control samples) together. To assess the effect of genotype and EE on mouse striatal gene expression, gene expression values were analyzed with an ANOVA model with 2 factors and an interaction term using the Limma software package (25, 26) . The 2 factors in the model were genotype (2 levels: control and R6/1) and treatment (2 levels: NE or EE). To examine the potential enrichment effect on HDdysregulated genes, we considered potential differences in the expression of the 61 mRNAs identified as differentially expressed in R6/1 mice by the criterion of FDR less than 0.05. To test the specificity of the effect of enrichment on gene expression, we modeled the relationship between the 2 variables (R6/1 EE vs WT NE to R6/1 NE vs WT NE) for all probe sets present on the microarray using a LOWESS model (27) .
Quantitative Reverse TranscriptionYPolymerase Chain Reaction Analyses
Quantitative reverse transcriptionYpolymerase chain reaction (RT-PCR) analyses were performed as described (28) . Briefly, reverse transcription of 5 Kg of total RNA was performed with a SuperScript First-Strand Synthesis System using random hexamer primers according to the manufacturer's instructions (Invitrogen, Carlsbad, CA). Quantitative polymerase chain reaction studies were performed with a Bio-Rad iCycler (BioRad, Hercules, CA) with SYBR-Green PCR Master Mix (Applied Biosystems, Foster City, CA) through 50 PCR cycles at 95-C for 30 seconds, at 57-C for 60 seconds, and at 72-C for 90 seconds. Primer and probe sequences are provided in Table, Supplemental Digital Content 1 (http://links.lww.com/NEN/A137), with the exception of the reference genes that were obtained as premixed reactions from PrimerDesign (Southampton, UK). Relative quantification was performed with an optimized panel of 3 housekeeping genes according to the dissected brain region surveyed (29) . Differences between samples were assessed using ANOVA followed by a post hoc test with Bonferroni correction.
Neuronal Intranuclear Inclusion Quantification
Ubiquitin IHC was performed as described (28) on 12-Km-thick parasagittal sections from frozen mouse brain. Brain regions were visualized using a 100Â water immersion lens (Leica, Solms, Germany). Inclusions were counted and sized using the Microcomputer Imaging Device M1 program set on grain counting mode and calibrated to the 100Â lens (horizontal, 4.080 pixels/Km; vertical, 4.860 pixels/Km). Images were obtained through a CCD camera controller (DAGE MTI model no. CCD72; MCID, Cambridge, UK) attached to the microscope. Optical density threshold values were set to capture inclusions within given size and density ranges to exclude artifacts as follows: 0.08 Km 2 G area G 10 Km 2 , 0 relative optical density unit G density G 3 relative optical density units. Inclusions were analyzed for the number and size in 6 brain regions: striatum, cortex, cerebellar granule cell layer, dentate gyrus of the hippocampus, CA1 subfield of the hippocampus, and CA3 subfield of the hippocampus. For each region of each animal, 3 nonoverlapping 100Â fields were scanned for the analysis. The data were pooled and analyzed with StatView statistical software (version 4.51; Abacus Concepts, Piscataway, NJ) using repeated-measures ANOVA (n = 3, repeated fields, at least 6 animals per group). Statistical significance was obtained at p G 0.05.
Electron Microscopy
At the age of 48 weeks, R6/1 mice (9 EE and 4 NE) and littermate controls (2 EE and 3 NE) were fixed by perfusion with PBS containing 4% paraformaldehyde and 0.2% glutaraldehyde. After perfusion, the brains were removed, postfixed with 4% paraformaldehyde in PBS overnight at 4-C, and then sectioned using a microtome. Sections were postfixed in 1% osmium tetroxide (BDH, Poole, UK), stained with 0.5% uranyl acetate (BDH), and embedded in resin (equal parts of araldite, and dodecenyl succinic anhydride, with 0.5% BDMA catalyst [all from Agar Scientific, Stansted, UK]). Tissue blocks were resectioned at 70 nm, counterstained with lead citrate before examination on an electron microscope (JEM-100CX; JEOL Ltd, Tokyo, Japan). Electron micrographs were obtained of 10 inclusion profiles from the anterior cingulate cortex and dorsal striatum of each animal; maximum and minimum diameters of inclusion profiles were measured using Adobe Photoshop.
In Situ Hybridization
Messenger RNA in situ hybridization was used as described (22) to assay exon 1 transgene expression levels with a probe targeted against a human-specific intron of the human HTT transgene sequence (TG3, 5 ¶ TCTGGGTTGCT GGGTCACTCTGTCTCTGCGGAGCCGGGGG 3 ¶). Sections were apposed to Amersham A-max autoradiography film for 2 weeks (Amersham). In situ hybridization signal was analyzed by measuring film densities using the M1 computer-based image analysis system. Mean signal values (absolute optical density) were obtained for each brain region: striatum, superficial layers of frontal cortex, deep layers of frontal cortex, entorhinal cortex, CA1 region of hippocampus, CA3 region of hippocampus, dentate gyrus of hippocampus, thalamus, and cerebellar granule and molecular cell layers. A comparison of EE and NE TG mice (for each brain region) was performed using 1-and 2-way ANOVA with Bonferroni-Dunn post hoc test. Data are presented as means T SEM. For these analyses, statistical significance was defined as p G 0.01.
RESULTS
Environmental Enrichment Does Not Preserve Neurotransmitter Receptor Binding Levels
Dopamine D 1 , dopamine D 2 , and adenosine A 2a receptors are downregulated in the striatum of R6/1 TG HD mice (11) . Decreases in levels of these receptors recapitulate human HD brain pathology and precede disease onset. Because EE might exert its beneficial effects by preserving levels of those neurotransmitter receptors, we measured levels of dopamine Inasmuch as R6/1 EE mice already show evidence of improved phenotype by the age of 12 weeks (16), this suggests that EE exerts its beneficial effects through a mechanism other than preservation of dopamine and adenosine receptors.
Dysregulated Gene Expression in R6/1 Mice
We previously analyzed the disease-related global differential mRNA expression in R6/2 mice and observed similar dysregulation of individual mRNAs in R6/1 mice (11, 12) . Here, we measured global differential gene expression in 24-week-old R6/1 mice by microarray analysis and compared its similarities with 6-week-old R6/2 mice. After correction for multiple testing (FDR G 0.05 [30] ), 61 mRNAs showed differential expression in R6/1 animals (59 decreased and 2 increased; Table, Supplemental Digital Content 2, http://links.lww.com/NEN/A138). Consistent with previous analyses in other mouse models, there was downregulation of molecules involved in striatal signaling pathways (12) .
To compare the R6/1 and R6/2 data sets, we first mapped parallel array probe sets to a nonredundant set of genes. We then assessed the relationship between the top 200 differentially expressed genes in R6/1 and the expression measures of those same genes in the R6/2 (Fig. 2) . The association of the gene expression changes in R6/1 and their corresponding dysregulation in R6/2 was tested using the Kendall T. This analysis showed a highly significant relationship between the transcriptional changes in these 2 models of HD (T = 0.33, p = 2 Â 10 j12 ). The top 50 concordant gene expression changes in R6/1 and R6/2 mice (defined as expression changes of identical directions in both models) are listed in 
Assessment of EE Effects on Gene Expression
Previous studies suggest that gene expression is an immediate substrate for the effects of EE (31Y33). Thus, we asked whether EE-related changes in gene expression could Knck1, potassium channel, subfamily K, member 2; Mbp, myelin basic protein; Nr4a2, nuclear receptor subfamily 4, group A, member 2; Penk1, preproenkephalin; Uchl1, ubiquitin carboxyl-terminal hydrolase L1; Usp2, ubiquitin specific peptidase 2. also be observed in an extended exposure paradigm. Assessment of the EE effect in the microarray data from WT animals alone or the combined set of R6/1 and WT animals demonstrated no statistically significant differences. To determine whether changes in gene expression might have escaped statistical detection because of the small sample size, we also explored the predicted changes at the mRNA and protein levels in a separate, larger, cohort of animals (n = 8/8). These results were also negative (data not shown), suggesting that, if gene expression effects of enrichment in WT animals are present, either they are of small magnitude or they vary sufficiently between animals that they escaped detection using these methods.
We next assessed whether EE could specifically mitigate the transcriptional effects of mutant huntingtin. For this analysis, we considered the set of 61 genes showing a significant genotype effect (FDR G 0.05) and asked if differential expression of these genes in R6/1 was modulated when these mice were provided with EE (Fig. 3A) . This plot indicates that the differential expression measures from R6/1 EE versus WT NE were uniformly of smaller absolute value than in R6/1 NE versus WT NE, suggesting the potential amelioration by enrichment of disease-related mRNA changes. To test the specificity of a hypothetical effect of EE on disease-related gene expression, we plotted the differential expression measures for R6/1 EE (vs WT NE) versus R6/1 NE (vs WT NE) for all genes on the array (Fig. 3B ). This analysis showed that the absolute magnitudes of differential expression measures for R6/1 EE samples were smaller for all probe sets than those of R6/1 NE samples. We interpreted this as a systematic bias in the expression measures, and this led us to dismiss the relevance of the amelioration by EE suggested for the set of 61 genes showing a significant genotype effect (Fig. 3A) . Nonetheless, the absence of EE-related changes detectable by microarray suggests that transcription is not a major substrate of the long-term EE effect.
Microarray analyses are limited in identifying potentially subtle effects of EE on disease-related gene expression. We therefore surveyed the effect of long-term EE in a panel of striatal genes that were most modulated by EE in microarray analyses using real-time RT-PCR analyses. We interrogated total RNA extracted from the striatum of 24-weekold WT and R6/2 mice exposed to either NE or EE. To determine the expression levels, we chose to use the geometric mean of 3 reference genes (Atp5b, Eif4a2, and Yhwaz) as a normalization strategy in relative quantification analyses (29) (Fig. 3C; Figure, Supplemental Digital Content 4, http://links.lww.com/NEN/A140). We observed no effect of EE on transprotein-induced transcriptional dysregulation for most genes surveyed, namely, Drd2 (dopamine D 2 receptor), Darpp32 (dopamine and cAMP-regulated neuronal phosphoprotein), Igfbp5 (insulin-like growth factor binding protein 5 precursor), Penk1 ( preproenkephalin), Mbp (myelin basic protein), Uchl1 (ubiquitin carboxyl-terminal hydrolase L1), and A2a (adenosine A 2a receptor; Fig. 3C ). However, there was a correction or a trend toward correction of the transproteininduced dysregulation in EE R6/1 striatum for some genes: Hpca (hippocalcin), Itpr3 (inositol 1,4,5-triphosphate receptor 3), Knck1 (potassium channel, subfamily K, member 2), Nr4a2 (nuclear receptor subfamily 4, group A, member 2), and Usp2 (ubiquitin specific peptidase 2; Fig. 3C ). Interestingly, although the endogenous murine Huntingtin gene (Hdh) was not dysregulated in R6/1 TG mice, we observed upregulation of Hdh gene expression in EE mice irrespective of genotype; this upregulation was significant in EE R6/1 mice (Fig. 3C) .
Environmental Enrichment Reduces NII Accumulation
Environmental enrichment has been previously reported to influence the clearance of insoluble protein aggregates (33, 34) . Although their role in disease pathogenesis remains unclear, the formation of ubiquitinated huntingtin aggregates in the nucleus is a hallmark of HD, and aggregate-clearing compounds have therapeutic benefits (35, 36) . Although cytoplasmic aggregates likely additionally play a role in HD pathogenesis (37) , accurate quantitation of the extranuclear inclusion burden is technically difficult. Therefore, we characterized the effect of EE on neuronal NII formation in the striatum, frontal cortex, and the cerebellar granule layer, as well as the CA1, CA3, and dentate gyrus subregions of the hippocampus.
There were no differences in NII numbers between NE and EE HD mice at the age of 12 weeks. Representative ubiquitin IHC is shown in Figure 4 for 24-week-old R6/1 mice. There were fewer NII in the dentate gyrus, striatum, frontal cortex, and cerebellar granule layers in the 24-weekold EE than in NE mice (Fig. 5A) . The areas of greatest difference in NII numbers were the striatum and the cerebellar granule cell layer.
There were no differences in NII size between 12-weekold EE and NE R6/1 mice, but NIIs were smaller in 24-weekold EE than in NE R6/1 mice in 5 of the 6 regions examined; the exception was the dentate gyrus (Fig. 5B) . This difference was striking because NII sizes more than triple over time in all regions examined in the NE HD mice.
We calculated a global measure of NII formation as a function of NII number and size for each region, which allowed comparisons of the extent of NII formation across regions in EE and NE R6/1 mice. BInclusion load[ was defined as the number of NII in each 100Â field multiplied by the mean NII size (Km 2 ) within that field. There was no difference in inclusion load in EE versus NE R6/1 mice at the age of 12 weeks, but 24-week-old EE R6/1 mice had decreased inclusion loads in all 6 regions measured compared with NE HD mice (Fig. 5C) . By calculating inclusion load values for each region at both ages, we obtained a crude measure of the rate of NII formation (Fig. 6) . The brain regions with the highest rate of inclusion formation were the same as those with the highest inclusion load: CA1 9 CA3 9 dentate gyrus 9 frontal cortex 9 cerebellar granule cells 9 striatum. Taken together, these data suggest that EE effectively reduces NII formation in all brain regions examined, with the greatest reduction in cerebellar granule cells (0.079 times the rate of NE mice) and the least reduction in the hippocampal CA1 region (0.327 times that of NE mice).
Ultrastructural Characterization of Inclusions
The effect of EE on NII was examined by electron microscopy as previously described (6) . As expected, there were NIIs in the anterior cingulate cortex and dorsal striatum of R6/1 TG mice at 48 weeks and in none of the WT controls (Fig. 7) . Neuronal intranuclear inclusions often have an oval profile, particularly in the cortex. In the anterior cingulate cortex, EE significantly decreased the minimum inclusion diameter from 1.35 T 0.36 to 1.14 T 0.34 Km (p = 0.0081, t-test; n = 6 animals, 49 inclusions EE, and 4 animals, 40 inclusions NE). In contrast to data from earlier stages, the effect of enrichment on inclusion size did not extend to the striatum. Invaginations in the neuronal nuclear membranes were also seen in the striatum and cortex of R6/1 mice, but there was no apparent effect of EE on the presence of nuclear membrane invaginations.
Transgene mRNA Expression Levels
Improvement in phenotype and decreased aggregate parameters in EE mice might result from decreased expression of the mutant transgene. However, because of the propensity of the TG protein to aggregate, it is not possible to determine any change in the protein expression levels by Western blot analysis. Therefore, we performed mRNA in situ hybridization using a transgene-specific oligonucleotide probe (Fig. 8A) . Densitometry was performed on 10 separate brain regions, and the absolute optical density was calculated. We found no difference in the level of transgene mRNA expression between 24-week-old EE and NE R6/1 mice for any brain region, and we did not observe environment effects by 2-way ANOVA (F 1,100 = 0.204, p = 0.6525). To ensure that the pattern of expression within the brain was consistent between the groups, we calculated correlation coefficients for all brain regions and found no difference between EE and NE mice (R 2 = 0.95, data not shown). We confirmed that there was no difference in transgene mRNA expression in the striatum of NE and EE R6/1 mice by quantitative RT-PCR (Fig. 8B) .
DISCUSSION
Complex sensory, motor, and cognitive environmental stimulation delays the onset and improves the molecular and morphologic aspects in R6/1 and R6/2 mouse models of HD, suggesting that EE may override some genetic constraints (2, 16Y18, 20, 21, 38Y40) . We found that neurotransmitter FIGURE 7 . Electron microscopy of NIIs showing decreased cortical NII size in old environmentally enriched R6/1 mice compared with NE mice. Neuronal intranuclear inclusion (white arrows) and indentations in the nuclear membrane (black arrows) are found in both the anterior cingulate cortex and dorsal striatum of R6/1 mice (a). Nuclear membrane invaginations are also present in control cortex at this age, but in the striatum, they are only found in R6/1 mice. Measurements of NII diameter show a decrease in size in the anterior cingulate cortex in EE mice (b). Scale bars 0 cortex, 1 Km; striatum, 3 Km. *, p G 0.01.
receptor binding in EE HD TG mice did not decline to the same extent as in their NE counterparts, although this preservation was not significant. We confirmed that the transcriptional phenotype in R6/1 HD TG mice was essentially identical to that of R6/2, thereby demonstrating the consistency in exon 1 transprotein effects.
Surprisingly, we were unable to detect any effect of longterm EE on gene expression profiles, even for those genes coding for proteins previously shown to be positively modulated in HD TG mice in response to an EE such as BDNF or the cannabinoid receptor subunit 1 (19, 20) . Similarly, we were unable to detect changes in microarray expression levels for neurotrophic factors, glutamate receptor subunits, or levels of other experience-dependent synaptic proteins such as PSD95 or synaptophysin, all of which are candidates for modulation by EE (40) . However, there are some considerations that may affect determination of EE effects on gene expression. Motor deficits were exhibited by a proportion of the mice (40% of EE mice vs 100% of NE mice). The effects of EE on the microarray data may thus be difficult to identify because of the heterogeneity of the populations. Inasmuch as a functionally challenged animal is less able to interact with the environment, the likelihood of displaying beneficial gene expression changes is reduced. Sex is an additional factor that contributes to the sample heterogeneity because mice of both sexes were used. Indeed, sex-specific differences in gene expression changes with EE in the R6/1 HD mouse models have been reported (41, 42) . The phenomenon of sex-environment interaction is not limited to HD, and further investigation is warranted.
Expression levels evaluated on a single gene-based quantitative RT-PCR suggested that long-term EE did exert specific effects, that is, there was a trend toward correction of some, but not all, of the transprotein-induced gene expression dysregulation. Although we did not observe statistically significant modulation of gene expression dysregulation by EE, the present study only examined effects of long-term EE, and we cannot rule out the possibility that there may have been immediate responses in gene expression that had beneficial long-term effects. Furthermore, we surveyed only a limited set of genes that did not include all candidates of interest such as experience-dependent synaptic proteins. In addition, we analyzed Bdnf gene expression in the cortex but found no effect of EE on Bdnf dysregulation (Figure, Supplemental Digital Content 4, http://links.lww.com/NEN/A140). Clearly, a more detailed survey of gene expression responses to EE in R6/1 mice over time is warranted. Similarly, protein expression levels of dysregulated genes that are additionally governed by posttranslational modifications and transcriptional modulations in response to EE need more detailed investigation.
Environmental enrichment may operate via mechanisms distinct from those disrupted by mutant exon 1 huntingtin. Furthermore, inclusions and abnormal protein expression levels (possibly mediated through transcriptional dysregulation) may represent independent pathological mechanisms in HD. Indeed, others have observed aggregation-related and unrelated mechanisms in response to EE (34), and we have observed that the presence of inclusions in R6/2 striatal neurons has no relationship to the degree of mRNA downregulation in these neurons (28) .
Mutant Htt is proteolytically cleaved to generate an Nterminal fragment that is prone to forming intracellular aggregates in neuronal neuropil and nuclei. It is not known whether the toxic form of huntingtin is a misfolded polyglutamine, oligomeric huntingtin, or fibrillar aggregate. The role of aggregates in HD is controversial. Some researchers argue that aggregates are toxic and lead to neurodegeneration, whereas others suggest that they are a mere by-product of the pathological manifestation (43) . Others suggest a neuroprotective role for aggregates as a molecular sink for putative soluble toxic Htt forms. However, regardless of their role, the presence of aggregated huntingtin is currently regarded to be inextricably linked with HD pathogenesis. Indeed, mutant Htt aggregates are now considered a major neuropathological hallmark of HD. Because aggregation onset tends to occur before neurologic onset and accumulation of aggregates in brains of HD patients and animal models increases with disease progression, aggregates may represent markers of disease onset or progression (6, 7, 10, 44Y48) . Manipulations that FIGURE 8 . No change in transgene expression levels in EE versus NE R6/1 TG mice. (A) mRNA in situ hybridization with a transgene-specific probe was performed on brains from each group. No specific staining was seen in the representative images of WT mice, irrespective of the environment in which they were reared, or in sections from TG R6/1 mice incubated in an excess of unlabeled probe (Cold). Transgene-specific staining appears dark in representative sections from NE and EE R6/1 TG mice. (B) Quantitative RT-PCR data using exon 1 transgene-specific primers on RNA extracted from striatum of 24-week-old mice show no difference in transgene expression between EE and NE R6/1 mice. Error bars, SEM.
extend the life span of TG HD mice tend to attenuate NII formation, thereby linking NII to the presence of neurologic manifestations (3).
We found a reduction in the rate of NII formation in EE animals over time in conjunction with phenotypic improvement. This result supports the hypothesis that aggregates are toxic. Our data also highlight the need for further detailed and sensitive mutant Htt aggregate characterization over time to determine the extent to which the beneficial effects of EE correlate with altered Htt aggregation and elucidate the molecular mechanisms underlying the reduction in aggregate load. Indeed, there are new aggregate quantitation methods that enable study of both NII and the cytoplasmic aggregates AGERA (48) and Seprion ligand (49) . In addition, examining gene expression rescue could provide new leads such as the finding that Usp2 is differentially modulated in EE R6/1 mice.
Using conditional TG HD mice, Yamamoto et al (50) demonstrated that turning off production of the mutant Htt transgene could reduce NII and improve the behavioral phenotype. This indicates that Htt inclusions are dynamic and that there must be catabolic mechanisms for dismantling inclusions. Our current result that EE decreases the rate of NII formation in all brain regions without turning off transgene expression suggests that EE might induce generally beneficial effects within the brain (thus boosting neuronal health and function), including the mechanisms responsible for dismantling inclusions. Indeed, EE is beneficial in other HD paradigms (51) ; in aging of WT rodents; in mouse models of Alzheimer disease, Parkinson disease, and Fragile X syndrome; and in brain injury/trauma (2, 30Y32, 38, 52Y54). The benefit of EE in mouse models of Alzheimer disease is not correlated with reduction of insoluble protein aggregates. Nonetheless, EE may have particular relevance to the treatment of neurodegenerative diseases, the hallmarks of which are insoluble aggregates of misfolded proteins.
Finally, the beneficial effects of enrichment may not be sufficient to overcome the aggressive phenotype of the R6 mice. The toxicity exerted by the continuously expressed TG protein seems to overcome the beneficial effects of EE. Despite the clearly delayed phenotype onset and progression with EE, TG mice still start to display debilitating motor and cognitive manifestations that may cause them to interact less with their environment, leading to a vicious circle. Consistent with this notion, the effects of EE on neuronal inclusions are more dramatic at earlier than at later time points. Environmental enrichment may have more benefit in HD mice that have a more gradual disease course, such as full-length TG, or knock-in models. Similarly, EE might be especially helpful in humans with HD, in whom the course of illness is usually 15 to 20 years. This notion is supported by data suggesting an interaction between genetic and environmental factors in HD (55Y57). Furthermore, the absence of adverse effects and the ease of incorporation into a patient's lifestyle strongly promote EE as a potential therapeutic approach in HD.
